Mitotane 500mg Tablets

Mitotane 500mg Tablets is a specialized adrenal cytotoxic agent that serves as the cornerstone of therapy for advanced Adrenal Cortical Carcinoma (ACC). Chemically related to the insecticide DDT, Mitotane 500mg Tablets possesses a unique “adrenolytic” capability; it selectively targets and destroys the mitochondria within the cells of the adrenal cortex. This targeted cellular destruction leads to necrosis (tissue death) of the adrenal tumor and a subsequent reduction in tumor mass. Concurrently, the medication fundamentally alters the peripheral metabolism of cortisol, converting it into inactive metabolites specifically 6-beta-hydroxycortisol, thereby rapidly decreasing the excessive hormone levels responsible for the debilitating symptoms of Cushing’s syndrome often associated with these tumors. Discover how this professional pharmaceutical intervention provides the ultimate clinical strategy for managing this rare and aggressive malignancy, offering patients effective relief and a chance for disease control when surgical options are exhausted or to prevent recurrence after resection.

Indications / Uses of Mitotane 500mg Tablets

Mitotane 500mg Tablets is commonly prescribed for the specialized management of adrenal pathologies:

• Adrenal Cortical Carcinoma (ACC): It is indicated for the treatment of inoperable, functional or non-functional, adrenal cortical carcinoma. It is the only approved drug specifically for this condition and is used to shrink tumors and control symptoms.
• Adjuvant Therapy: The medication is frequently used as an adjuvant therapy after the surgical removal of adrenal tumors to eliminate any microscopic residual disease and prolong recurrence-free survival.
• Cushing’s Syndrome (Hypercortisolism): In specific clinical scenarios, Mitotane 500mg Tablets is utilized to control severe hypercortisolism (excessive cortisol production) resulting from adrenal tumors or pituitary-dependent Cushing’s disease when other treatments have failed.

Key Features

• Selective Adrenolytic Action: The primary feature of Mitotane 500mg Tablets is its specificity; it targets the adrenal cortex almost exclusively, effectively performing a “medical adrenalectomy” without damaging other organs.
• Steroid Suppression: It powerfully suppresses the production of corticosteroids, rapidly alleviating symptoms of hormone excess such as weight gain, hypertension, and glucose intolerance.
• Lipophilic Nature: The drug is highly soluble in fat and accumulates in adipose tissue, resulting in a very long half-life (weeks to months), which ensures sustained therapeutic levels even after dosing is paused.
• Standardized 500mg Strength: The 500mg tablet allows for the high-dose titration regimens (often 2g to 6g daily) required to reach the therapeutic plasma concentration window (14–20 mg/L).
• Oral Administration: It offers a non-invasive route of administration for chronic management of a complex endocrine malignancy.

Storage for Mitotane 500mg Tablets

To preserve the pharmacological stability and ultimate potency of the active ingredients, Mitotane 500mg Tablets should be stored at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F). Deviations are permitted between 15°C and 30°C (59°F to 86°F). It is vital to keep the tablets in their original, tight, light-resistant container until the moment of use. Because the drug is chemically stable but potent, ensure the bottle cap is always tightly secured. For maximum safety, always store Mitotane 500mg Tablets in a secure, high location that is strictly out of the reach and sight of children and pets. Do not dispose of unused tablets in household trash; follow hazardous drug disposal guidelines.

Important Note on Mitotane 500mg Tablets

The administration of Mitotane 500mg Tablets requires critical endocrine monitoring. The most significant risk is adrenal insufficiency. Because the drug destroys adrenal tissue and alters cortisol metabolism, patients will inevitably develop a lack of necessary steroid hormones. Steroid replacement therapy (glucocorticoids and mineralocorticoids) is mandatory for nearly all patients taking this medication.

Adrenal Crisis Warning: In times of physiological stress—such as shock, severe trauma, or infection—the body cannot produce the cortisol surge needed to survive. Patients on Mitotane 500mg Tablets must discontinue the drug immediately in such events and receive aggressive intravenous steroid replacement. Patients should carry a medical alert card stating they are on an adrenolytic agent.

Central Nervous System (CNS) toxicity is common; symptoms include lethargy, somnolence, vertigo, and dizziness. These side effects are often dose-dependent and reversible. Gastrointestinal disturbances (severe nausea, vomiting, diarrhea) are also frequent; taking the tablets with fatty food can improve absorption and reduce stomach upset. Mitotane 500mg Tablets is a potent inducer of liver enzymes (CYP3A4), meaning it can destroy other medications (like warfarin) very quickly, rendering them ineffective; medication reviews are essential. By strictly following these professional guidelines and replacement steroid protocols, patients can safely manage the delicate hormonal balance while treating the malignancy.